clofibrate and gw 9578

clofibrate has been researched along with gw 9578 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brown, PJ; Henke, BR; Sternbach, DD; Willson, TM1
Berthelot, P; Chavatte, P; Desreumaux, P; Farce, A; Furman, C; Lebègue, N; Millet, R; Pirat, C; Renault, N; Speca, S; Yous, S1
Berge, RK; Derudas, B; Fruchart, JC; Gervois, P; Guerre-Millo, M; Herbert, JM; Madsen, L; Poulain, P; Raspé, E; Staels, B; Willson, TM; Winegar, DA1

Reviews

2 review(s) available for clofibrate and gw 9578

ArticleYear
The PPARs: from orphan receptors to drug discovery.
    Journal of medicinal chemistry, 2000, Feb-24, Volume: 43, Issue:4

    Topics: Animals; Diabetes Mellitus; Drug Design; Humans; Hyperlipidemias; Hypertension; Inflammation; Ligands; Models, Molecular; Neoplasms; Nuclear Proteins; Obesity; Receptors, Cytoplasmic and Nuclear; Transcription Factors

2000
Targeting peroxisome proliferator-activated receptors (PPARs): development of modulators.
    Journal of medicinal chemistry, 2012, May-10, Volume: 55, Issue:9

    Topics: Animals; Humans; Ligands; Metabolic Syndrome; Models, Molecular; Molecular Targeted Therapy; Peroxisome Proliferator-Activated Receptors

2012

Other Studies

1 other study(ies) available for clofibrate and gw 9578

ArticleYear
Peroxisome proliferator-activated receptor alpha activators improve insulin sensitivity and reduce adiposity.
    The Journal of biological chemistry, 2000, Jun-02, Volume: 275, Issue:22

    Topics: Adipose Tissue; Animals; Butyrates; Clofibrate; Fenofibrate; Hypolipidemic Agents; Insulin Resistance; Male; Mice; Mice, Inbred C57BL; Obesity; Phenylurea Compounds; Rats; Rats, Zucker; Receptors, Cytoplasmic and Nuclear; Transcription Factors

2000